Impact of Congenital Heart Disease Versus Acquired Heart Disease: An Analysis of 181 Patients who Underwent Cardiac Transplantation
- 26 November 2025
- journal article
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 17 (3) , 343-351
Abstract
Purpose: We reviewed all 181 patients with pediatric and/or congenital heart disease (CHD) who underwent cardiac transplantation at the University of Florida from January 1, 2011, to March 1, 2022, and compared those with CHD with those who had acquired heart disease (AHD). Methods: Patient characteristics were assessed, stratified by CHD versus AHD. Continuous variables are presented as mean (SD); median[interquartile range](range). Categorical variables are presented as N (%). Univariable associations with long-term mortality were assessed with a Cox proportional-hazards model. The impact of CHD versus AHD on mortality was estimated with multivariable models. The Kaplan-Meier method was applied to estimate survival stratified by CHD versus AHD status. Results: Congenital heart disease was present in 112/181 patients = 61.9% of the total cohort. Acquired heart disease was present in 69/181 = 38.1%. More patients with CHD had prior cardiac surgery (95/112 = 84.8% vs 35/69 = 50.7%, P < .0001) and pretransplant liver dysfunction (19/112 = 17.0% vs 4/69 = 5.8%, P = .037). Congenital heart disease patients had longer bypass times (minutes): 148 (55.2); 137 [113-174] (72-526) versus 108 (40.3);101 [81-125] (59-300), P < .0001; longer cross clamp time (minutes): 85.9 (21.2); 85 [73-100] (49-152) versus 66.3 (14.7); 65 [55-75] (44-106), P < .0001; and lower minimum temperature on bypass (°C): 27.4 (4.3); 28 [24-31] (19-34) versus 31.6 (3.1); 32 [31-34] (20-36), P < .0001. Posttransplant length of stay (days) was longer in CHD patients: 34.5 (26.8); 27 [19-40] (3-158) versus 29.7 (48.2); 18 [15-26] (0-343), P = .0001. In multivariable analysis, CHD remained a risk factor for mortality after controlling for all variables significant in univariable modeling. Overall Kaplan-Meier 5-year survival in all 181 patients (95% confidence interval) = 85.8% (80.0%-92.1%). Kaplan-Meier 5-year survival = 77.4% (68.4%-87.5%) in CHD and 98.5% (95.6%-99.9%) in AHD, P < .0001. Conclusion: Congenital heart disease is a risk factor for mortality after cardiac transplantation. Efforts must be made to understand and mitigate this risk.Keywords
This publication has 24 references indexed in Scilit:
- An Analysis of 186 Transplants for Pediatric or Congenital Heart Disease: Impact of Pretransplant VADThe Annals of Thoracic Surgery, 2023
- Sixth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) ReportThe Annals of Thoracic Surgery, 2022
- An Analysis of 183 Heart Transplants for Pediatric or Congenital Heart Disease—Impact of High Panel Reactive AntibodyThe Annals of Thoracic Surgery, 2022
- Combined Hybrid Procedure and VAD Insertion in 9 High-Risk Neonates and Infants With HLHSThe Annals of Thoracic Surgery, 2022
- Waitlist Outcomes for Children With Congenital Heart Disease: Lessons Learned From Over 5000 Heart Transplant Listings in the United StatesJournal of Cardiac Failure, 2022
- Berlin Heart EXCOR and ACTION post-approval surveillance study reportThe Journal of Heart and Lung Transplantation, 2021
- Cumulative Effect of Preoperative Risk Factors on Mortality After Pediatric Heart TransplantationThe Annals of Thoracic Surgery, 2018
- The Registry of the International Society for Heart and Lung Transplantation: Seventeenth Official Pediatric Heart Transplantation Report—2014; Focus Theme: RetransplantationThe Journal of Heart and Lung Transplantation, 2014
- Rescue cardiac transplantation for failing staged palliation in patients with hypoplastic left heart syndromeCardiology in the Young, 2006
- Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist deviceThe Journal of Heart and Lung Transplantation, 2003